Studies on resistance of Schistosoma to praziquantel XIV experimental comparison of susceptibility to praziquantel between PZQ-resistant isolates and PZQ-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia and cercariae

Chinese Journal of Schistosomiasis Control

Volumn 23, Issue 6, 2011, Pages 611-619

  Li, Hong Jun ^a   Liang, You Sheng ^a   Dai, Jian Rong ^a   Wang, Wei ^a   Qu, Guo Li ^a   Li, You Zi ^a   Xing, Yun Tian ^a   Too, Yong Hui ^a   Qian, Ke ^a   Jia, Yue ^a   Yang, Zhen Kun ^a   Wei, Jian Ying ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Adult worm; Cercaria; Drag resistance; ED 50; Miracidium; Praziquantel; Schistosoma japonicum

Indexed keywords

PRAZIQUANTEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERCARIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DOSE COMPARISON; MESENTERIC VEIN; MIRACIDIUM; MORPHOLOGY; MOUSE; NONHUMAN; PARASITE ISOLATION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; TREATMENT RESPONSE;

ANIMALS; CERCARIA; CHINA; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; FEMALE; HUMANS; LIFE CYCLE STAGES; MALE; MICE; PARASITIC SENSITIVITY TESTS; PRAZIQUANTEL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMICIDES;

EID: 84863118177     PISSN: 10056661     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gönnert R, Andrews P. Praziquantel, a new board-spectrum antischistosomal agent[J]. Z Parasitenkd, 1977, 52(2): 129-150. (Pubitemid 8155044)
2. Seubert J, Pohlke R, Loebich F. Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against schistosomes and cestodes[J]. Experientia, 1977, 33(8): 1036-1037. (Pubitemid 8161201)
3. WHO. Controlling disease due to helminth infections[R]. WHO Technical Report Series No. 912, Geneva: Switzerland, 2002: 1-52.
4. Fallon PG, Doenhoff MJ. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific[J]. Am J Trop Med Hyg, 1994, 51(1): 83-88. (Pubitemid 24266292)
5. Fallon PG, Sturrock RF, Niang AC, et al. Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni[J]. Am J Trop Med Hyg, 1995, 53(1): 61-62.
6. Stelma FF, Talla I, Sow S, et al. Efficacy and side effects of praziquantel in an epidemic focus of Scistosoma mansoni[J]. Am J Trop Med Hyg, 1995, 53(2): 167-170.
7. Ismail M, Metally A, Farghaly A, et al. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high dose of praziquantel[J]. Am J Trop Med Hyg, 1996, 55(2): 214-218. (Pubitemid 26299209)
8. Melman SD, Steinauer ML, Cunningham C, et al. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni[J]. PLoS Negl Trop Dis, 2009, 3(8): e504.
9. Cioli D, Pica-Mattoccia L. Praziquantel[J]. Parasitol Res, 2003, 90(Suppl 1): S3-S9. (Pubitemid 36831287)
10. Ciloi D. Praziquantel: is there real resistance and are there alternative?[J]. Curr Opin Infect Dis, 2000, 13(6): 659-663.
11. Fenwick A, Webster JP. Schistosomiasis: challenges for control, treatment and drug resistance[J]. Curr Opin Infect Dis, 2006, 19(6): 577-582. (Pubitemid 44665464)
12. Wang W, Dai JR, Li HJ, et al. Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China[J]. Parasitology, 2010, 137(13): 1905-1912.
13. Lamberton PH, Hogan SC, Kabatereine NB, et al. In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections[J]. Am J Trop Med Hyg, 2010, 83(6): 1340-1347.
14. 50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates[J]. Int J Parasitol, 2004, 34(8): 979-987.
15. 50 determination[J]. Int J Parasitol, 2004, 34(8): 971-977.
16. Liang YS, Coles GC, Doenhoff MJ, et al. In vitro responses of praziquantel-resistant and-susceptible Schistosoma mansoni to praziquantel[J]. Int J Parasitol, 2001, 31(11): 1227-1235. (Pubitemid 32762993)
17. Liang YS, Wang W, Dai JR, et al. Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni[J]. J Helminthol, 2010, 84(2): 202-207.
18. Liang YS, Dai JR, Ning A, et al. Susceptibility of Schistosoma japonicum to praziquantel in China[J]. Trop Med Int Health, 2001, 6(9):707-714. (Pubitemid 32823109)
19. Ismail M, Attia M, Metweally AA, et al. Assessment of praziquantel therapy in treatment of Schistosoma mansoni infection[J]. J Egypt Soc Parasitol, 1994, 24(1): 231-238.
20. Bennett JL, Day T, Liang FT, et al. The development of resistance to anthelmintics: a perspective with emphasis on the antischistosomal drug praziquantel[J]. Exp Parasitol, 1997, 87(3): 260-267. (Pubitemid 27494330)
21. Botros S, Sabra A, William S. Miracidial assay as a simple, inexpensive biological test for sensitivity to praziquantel using field and laboratory praziquantel-susceptible and insusceptible Schistosoma mansoni isolates[J]. Aust J Basic Appl Sci, 2008, 2(3): 677-684.